Literature DB >> 27521336

Temporal Resolution of Misfolded Prion Protein Transport, Accumulation, Glial Activation, and Neuronal Death in the Retinas of Mice Inoculated with Scrapie.

M Heather West Greenlee1, Melissa Lind2, Robyn Kokemuller3, Najiba Mammadova3, Naveen Kondru2, Sireesha Manne2, Jodi Smith3, Anumantha Kanthasamy2, Justin Greenlee3.   

Abstract

Currently, there is a lack of pathological landmarks to describe the progression of prion disease in vivo. Our goal was to use an experimental model to determine the temporal relationship between the transport of misfolded prion protein (PrP(Sc)) from the brain to the retina, the accumulation of PrP(Sc) in the retina, the response of the surrounding retinal tissue, and loss of neurons. Retinal samples from mice inoculated with RML scrapie were collected at 30, 60, 90, 105, and 120 days post inoculation (dpi) or at the onset of clinical signs of disease (153 dpi). Retinal homogenates were tested for prion seeding activity. Antibody staining was used to assess accumulation of PrP(Sc) and the resulting response of retinal tissue. Loss of photoreceptors was used as a measure of neuronal death. PrP(Sc) seeding activity was first detected in all samples at 60 dpi. Accumulation of PrP(Sc) and coincident activation of retinal glia were first detected at 90 dpi. Activation of microglia was first detected at 105 dpi, but neuronal death was not detectable until 120 dpi. Our results demonstrate that by using the retina we can resolve the temporal separation between several key events in the pathogenesis of prion disease.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27521336      PMCID: PMC5012505          DOI: 10.1016/j.ajpath.2016.05.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

Review 1.  New approaches for the selection and evaluation of anti-prion organic compounds.

Authors:  Yraima Cordeiro; Natalia C Ferreira
Journal:  Mini Rev Med Chem       Date:  2015       Impact factor: 3.862

2.  Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.

Authors:  Thomas G Beach; Jeremiah Carew; Geidy Serrano; Charles H Adler; Holly A Shill; Lucia I Sue; Marwan N Sabbagh; Haruhiko Akiyama; Nicolás Cuenca
Journal:  Neurosci Lett       Date:  2014-04-28       Impact factor: 3.046

Review 3.  Clinical update of Jakob-Creutzfeldt disease.

Authors:  Mee-Ohk Kim; Michael D Geschwind
Journal:  Curr Opin Neurol       Date:  2015-06       Impact factor: 5.710

4.  Characterization of retinal architecture in Parkinson's disease.

Authors:  Jessica Chorostecki; Navid Seraji-Bozorgzad; Aashka Shah; Fen Bao; Ginny Bao; Edwin George; Veronica Gorden; Christina Caon; Elliot Frohman; M Tariq Bhatti; Omar Khan
Journal:  J Neurol Sci       Date:  2015-05-12       Impact factor: 3.181

5.  Retrograde transport of transmissible mink encephalopathy within descending motor tracts.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Photoreceptor degeneration during infection with various strains of the scrapie agent in hamsters.

Authors:  N C Buyukmihci; F Goehring-Harmon; R F Marsh
Journal:  Exp Neurol       Date:  1987-07       Impact factor: 5.330

7.  Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays.

Authors:  Jason M Wilham; Christina D Orrú; Richard A Bessen; Ryuichiro Atarashi; Kazunori Sano; Brent Race; Kimberly D Meade-White; Lara M Taubner; Andrew Timmes; Byron Caughey
Journal:  PLoS Pathog       Date:  2010-12-02       Impact factor: 6.823

Review 8.  Prion diseases--close to effective therapy?

Authors:  Neil R Cashman; Byron Caughey
Journal:  Nat Rev Drug Discov       Date:  2004-10       Impact factor: 84.694

9.  Analysis of prion protein aggregates in blood and brain from pre-clinical and clinical BSE cases.

Authors:  O Bannach; E Reinartz; F Henke; F Dreßen; A Oelschlegel; M Kaatz; M H Groschup; D Willbold; D Riesner; E Birkmann
Journal:  Vet Microbiol       Date:  2013-06-14       Impact factor: 3.293

10.  Factors affecting the accuracy of urine-based biomarkers of BSE.

Authors:  Margot Plews; Lise Lamoureux; Sharon Lr Simon; Catherine Graham; Viola Ruddat; Stefanie Czub; J David Knox
Journal:  Proteome Sci       Date:  2011-02-07       Impact factor: 2.480

View more
  21 in total

1.  Experimental Transmission of the Chronic Wasting Disease Agent to Swine after Oral or Intracranial Inoculation.

Authors:  S Jo Moore; M Heather West Greenlee; Naveen Kondru; Sireesha Manne; Jodi D Smith; Robert A Kunkle; Anumantha Kanthasamy; Justin J Greenlee
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

2.  Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.

Authors:  Natallia Makarava; Jennifer Chen-Yu Chang; Kara Molesworth; Ilia V Baskakov
Journal:  Neurobiol Dis       Date:  2020-01-27       Impact factor: 5.996

Review 3.  Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease.

Authors:  Robert I Richards; Sarah A Robertson; Daniel L Kastner
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

4.  Ante-mortem detection of chronic wasting disease in recto-anal mucosa-associated lymphoid tissues from elk (Cervus elaphus nelsoni) using real-time quaking-induced conversion (RT-QuIC) assay: A blinded collaborative study.

Authors:  Sireesha Manne; Naveen Kondru; Tracy Nichols; Aaron Lehmkuhl; Bruce Thomsen; Rodger Main; Patrick Halbur; Somak Dutta; Anumantha G Kanthasamy
Journal:  Prion       Date:  2017-11-03       Impact factor: 3.931

Review 5.  Prions and prion diseases: Insights from the eye.

Authors:  Neena Singh; Suman Chaudhary; Ajay Ashok; Ewald Lindner
Journal:  Exp Eye Res       Date:  2020-08-25       Impact factor: 3.467

6.  Blinded RT-QuIC Analysis of α-Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients.

Authors:  Sireesha Manne; Naveen Kondru; Huajun Jin; Geidy E Serrano; Vellareddy Anantharam; Arthi Kanthasamy; Charles H Adler; Thomas G Beach; Anumantha G Kanthasamy
Journal:  Mov Disord       Date:  2020-09-22       Impact factor: 10.338

7.  α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients.

Authors:  Sireesha Manne; Naveen Kondru; Huajun Jin; Vellareddy Anantharam; Xuemei Huang; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Mov Disord       Date:  2019-11-23       Impact factor: 10.338

8.  Real-Time Quaking-Induced Conversion Detection of Bovine Spongiform Encephalopathy Prions in a Subclinical Steer.

Authors:  Soyoun Hwang; M Heather West Greenlee; Anne Balkema-Buschmann; Martin H Groschup; Eric M Nicholson; Justin J Greenlee
Journal:  Front Vet Sci       Date:  2018-01-19

9.  Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.

Authors:  Sireesha Manne; Naveen Kondru; Monica Hepker; Huajun Jin; Vellareddy Anantharam; Mechelle Lewis; Xuemei Huang; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-31       Impact factor: 4.147

10.  Prion protein facilitates retinal iron uptake and is cleaved at the β-site: Implications for retinal iron homeostasis in prion disorders.

Authors:  Abhishek Asthana; Shounak Baksi; Ajay Ashok; Shilpita Karmakar; Najiba Mammadova; Robyn Kokemuller; Mary Heather Greenlee; Qingzhong Kong; Neena Singh
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.